L-DOPA MICROBIOME THERAPY
Application
US20260076931A1
Kind: A1
Mar 19, 2026
Inventors
ANUMANTHA G. KANTHASAMY, Ahmed Abdalla, Gregory Phillips, Nicholas John Backes
Abstract
The present invention generally provides methods and compositions for the treatment of Parkinson's disease and depression and/or anxiety. The invention relates to recombinant microorganisms, particularly gut-colonizing probiotics, modified to produce L-DOPA.
CPC Classifications
A61K 31/198
A61K 9/0053
A61K 35/741
A61P 25/16
A61P 25/24
A61P 25/28
C12N 9/0073
A61K 2035/115
Filing Date
2025-11-20
Application No.
19395786